MPLT
MapLight Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.77
+4.79%Institutional positioning
13F filings over the trailing two quarters
New 62Increased 45Reduced 45Sold out 10
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Novo Holdings A/S | Unchanged | 3,686,622 | Aug 14, 2026 |
| NOVO HOLDINGS A/S | Unchanged | 3,686,622 | May 15, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 3,226,400 | Aug 14, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 3,226,400 | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Reduced | 2,801,937 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 2,781,728 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,994,873 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,948,312 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 1,937,168 | Mar 25, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 1,422,935 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 1,339,731 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 1,025,134 | Aug 7, 2026 |
| BLUE OWL CAPITAL HOLDINGS LP | Increased | 1,005,929 | May 14, 2026 |
| NAN FUNG GROUP HOLDINGS LTD | Unchanged | 971,253 | May 14, 2026 |
| Nan Fung Group Holdings Ltd | Unchanged | 971,253 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings